Fasenra

This page shows the latest Fasenra news and features for those working in and with pharma, biotech and healthcare.

AZ says target of $45bn sales by 2023 still achievable

The underlying picture is strong, however, with new medicines like Tagrisso, Imfinzi, Lynparza in cancer, Farxiga in diabetes and Fasenra in severe asthma growing 19% in the first nine months of ... In respiratory, interleukin-5 inhibitor Fasenra

Latest news

Dupixent helps put Sanofi back on growth track

Fasenra (benralizumab) all jostling for market share.
FDA rejects GSK’s Nucala for COPD

Fasenra (benralizumab) and Teva’s Cinqair/Cinqaero (reslizumab). ... In May, AZ’s Fasenra failed a phase III trial in this indication as it was unable to show a benefit compared to placebo reducing exacerbations.
FDA rejects GSK’s Nucala for COPD

Fasenra (benralizumab) and Teva’s Cinqair/Cinqaero (reslizumab). ... In May, AZ’s Fasenra failed a phase III trial in this indication as it was unable to show a benefit compared to placebo reducing exacerbations.
AZ, Amgen’s first-in-class asthma drug gets breakthrough status

Drugs like Fasenra and GlaxoSmithKline’s rival IL-5 inhibitor Nucala (mepolizumab) have emerged as an important treatment option for people with severe asthma characterised by high levels of eosinophils. ... Nucala made £245m ($317m) in the first six
New cancer drugs can’t quite plug the revenue hole at AZ

Fasenra (benralizumab) although overall respiratory sales were flat in the first half at $2.41bn. ... AZ’s decision to price IL-5 inhibitor Fasenra below rival products from GlaxoSmithKline and Teva seems to have helped get the drug moving quickly with

More from news
Approximately 6 fully matching, plus 10 partially matching documents found.

Latest Intelligence

AstraZeneca: building a new ‘open innovation’ pharma company

AstraZeneca launched five significant new medicines in 2017: immunotherapy Iminzi, Calquence for mantle cell lymphoma, Qtern in type 2 diabetes, Bevespi Aerosphere in COPD and Fasenra for severe asthma.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager- Healthcare Advertising: Negotiable

Associate Medical Director: Highly Competitive

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Associate Director: £75, 000-90, 000

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Director: Excellent benefits

Senior Medical Writer (Remote Working): Competitive Salary Offered

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Medical Writer: Great salary and benefits

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Medical Writer: Competitive Salary

Senior Account Executive, London, Medical Communications: Excellent package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Director: £48, 000 - £60, 000

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Healthcare Communications Account Directors x 2: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Future Market Insights

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI...

Latest intelligence

A reflection of ESMO: Client Relationship Director Fabienne Wild from Ashfield Meetings & Events reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO)....
OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....